knowledge -WSS

knowledge

author：entertainment 2025-09-06 03:53:23 - browse：61669

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The benefits and risks of Eli Lilly’s treatment for Alzheimer’s disease were confirmed in detailed scientific disclosures Monday, paving the way for its full approval but leaving physicians with lingering questions about the medicine’s impact on patients as a new era in Alzheimer’s therapy unfolds.

The drug, called donanemab, showed a 35% slowing of Alzheimer’s disease progression relative to placebo in a clinical trial that enrolled 1,700 patients with early-stage disease. Numerically, that’s a modest, 3.3-point improvement on a 144-point survey, called the Integrated Alzheimer’s Disease Rating Scale, or iADRS, that combines measures of cognition and function, such as driving, managing finances, or carrying on conversations.

There was a similar benefit when donanemab’s efficacy was assessed using a more common measure of cognition called the Clinical Dementia Rating-Sum of Boxes, or CDR-SB. On that scale, the Lilly drug showed a 36% slowing of cognitive decline relative to placebo, or 0.68 points on an 18-point scale.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Readout Newsletter: Parkinson's study, Gilead, CG Oncology

hotspot

Wikipedia

WSS

Inaction leaves children at risk from dangerous chemotherapy drug

Future doctors need a strong humanities education

FDA endorses new sterilization method for medical devices

Inaction leaves children at risk from dangerous chemotherapy drug

Inaction leaves children at risk from dangerous chemotherapy drug

Microsoft launches AI tool for clinical documentation through Epic

explore

knowledge

knowledge

Bright Health sells Medicare Advantage business to Molina

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Guidelines to prevent youth baseball injuries need more muscle

Why Charlie Gard's case is so disturbing to Americans

Trump demands the U.S. pay no more for drugs than other countries … again

CVS is on a mission to consolidate health care. Will it work?

Jerome Adams on the need for new antivirals for Covid

3 questions for the future of Biden's cancer moonshot

Continuity nursing helped my family in our darkest PICU moments

Cardiologists urge adding sexual orientation, gender identity to health records

hotspot

Why age limits for politicians are a terrible idea

Why Charlie Gard's case is so disturbing to Americans

Head of FDA's diagnostics center, who led through Covid, retires

TikTok, Instagram influencers need more rules for drug ads

3 questions for the future of Biden's cancer moonshot

There's an unseen cost to disruptive road

entertainment

hotspot

Wikipedia

focus